To validate whether inhibition of CMV70-3P decreases SOX2 protein expression, we used GBM13 patient-derived glioma cells (CMV positive) and U118 cells infected with CMV and then transduced with CMV70-3P or NCmiRNA. This evidence concerns the gene SOX2 and central nervous system cancer.